Related Experiment Videos
New developments in obsessive-compulsive disorder research: implications for clinical management
1Department of Psychiatry, Chaim Sheba Medical Center, Sackler Medical School, Tel Aviv University, Israel.
International Clinical Psychopharmacology
|December 1, 1996
Summary
Obsessive-compulsive disorder (OCD) is now understood as a common condition, not a rare illness. Advances in research and treatments like selective serotonin reuptake inhibitors (SSRIs) have improved patient outcomes.
Area of Science:
- Neuroscience
- Psychiatry
- Genetics
Background:
- Obsessive-compulsive disorder (OCD) was historically viewed as a rare, psychodynamic condition.
- Recent research indicates OCD affects 2-3% of the population, highlighting its prevalence.
- Significant personal and economic burdens are associated with OCD.
Purpose of the Study:
- To review recent research advancements in understanding OCD.
- To explore the impact of new findings on clinical management strategies for OCD.
Main Methods:
- Epidemiological studies
- Phenomenological research
- Pharmacological investigations
- Neurobiological research
- Brain imaging techniques
- Genetic research
Main Results:
- OCD is now recognized as a common disorder with a significant population impact.
- Serotonin reuptake inhibitors (clomipramine and SSRIs) demonstrate efficacy in treatment.
- Improved understanding of OCD pathophysiology is emerging through sophisticated research.
Conclusions:
- Enhanced recognition and effective treatments have improved OCD prognosis.
- Ongoing research continues to unravel the underlying pathophysiology of OCD.
- Future research holds potential for further advancements in clinical management.